Compulsive Overeating & Obesity

What This Is — And What It Isn’t

Compulsive overeating is commonly treated as a problem of willpower, discipline, or “lifestyle choices.” It is none of those things. It is driven by the same neurobiological reward mechanisms that underlie dependence on alcohol, opioids, stimulants, and other substances. Understanding this changes everything about how it should be treated.

The Neurobiology

The brain’s reward system evolved to reinforce behaviors essential for survival — eating foremost among them. Dopamine release in the mesolimbic pathway, particularly in the nucleus accumbens, signals that something is worth pursuing again. In a normally functioning system, this works: food produces a moderate dopamine response, the system recalibrates, and the drive to eat adjusts accordingly.

Highly palatable foods — engineered combinations of sugar, fat, and salt — produce dopamine responses that significantly exceed what the system was designed to handle. With repeated exposure, the same neuroadaptation that occurs in substance dependence takes hold: dopamine receptors downregulate, baseline reward sensitivity diminishes, and the threshold for experiencing satisfaction rises. The result is a pattern that anyone familiar with addiction will recognize — escalating consumption, diminishing returns, an inability to stop despite wanting to, and a pervasive sense of emptiness or agitation when not eating.

The prefrontal cortex, which normally exerts top-down control over impulsive behavior, shows functional impairment in compulsive overeating that mirrors what is seen in substance use disorders. The capacity to inhibit a behavior you know is harmful is genuinely compromised — not because the person lacks character, but because the neural circuitry responsible for that inhibition has been altered.

Hormonal dysregulation compounds the picture. Leptin resistance — a blunting of the brain’s response to the satiety signal that should tell you to stop eating — develops with chronic overeating and obesity. Ghrelin signaling, which drives hunger, becomes disordered. Insulin resistance further disrupts the metabolic feedback loops that normally regulate energy intake. The body is no longer receiving or processing the signals that would allow a person to eat normally, even if they desperately want to.

Why It Persists

The neurobiological picture explains why compulsive overeating is so resistant to conventional approaches — diets, exercise programs, calorie tracking, behavioral modification. These interventions address the surface of the problem while leaving the underlying reward system dysregulation and hormonal disruption untouched. A person whose dopamine system has downregulated and whose satiety signaling is impaired is being asked to override their own neurobiology through effort alone. It rarely works, and the failure compounds the shame that is already a significant part of the condition.

But the neurobiology is only part of the story. Compulsive overeating, like any form of addiction, is almost always managing something. Anxiety, depression, loneliness, histories of trauma or loss, a relationship to one’s own body and self that was never adequately understood — food has become the way of coping with experiences that have no other outlet. Addressing the biology without understanding what’s underneath it is incomplete. Addressing what’s underneath it while the biology remains destabilized is premature. Both need to happen, and they need to happen together.

GLP-1 Medications

The development of GLP-1 receptor agonist medications — semaglutide, liraglutide, tirzepatide, and others — has fundamentally changed what is possible in the treatment of compulsive overeating and obesity. These medications act on GLP-1 receptors in both the gut and the brain, reducing appetite, slowing gastric emptying, and — critically — modulating the dopamine reward circuitry that drives compulsive eating. Patients consistently describe what has come to be called the quieting of “food noise” — the relentless internal preoccupation with eating that dominates their mental life.

This is not simply appetite suppression. It is a neurological shift that allows a person, often for the first time, to experience a normal relationship with hunger and satiety. The compulsive drive loosens. The capacity to make choices about food — real choices, not white-knuckle resistance — returns. In the context of this practice, the parallel to Suboxone in opioid dependence is direct: the medication creates the neurological conditions that make the deeper therapeutic work possible.

I prescribe GLP-1 medications as part of an integrated treatment — not as a standalone weight loss intervention. The medication addresses the biology. The ongoing conversation addresses what the eating has been managing, what it has made possible to avoid, and what a different relationship with oneself might look like.

How I Approach It

I treat compulsive overeating as I treat any other form of addiction: as a serious condition with biological, psychological, and emotional dimensions, all of which need to be addressed. The medical piece — GLP-1 medication, management of metabolic complications, treatment of co-occurring conditions like depression, anxiety, or chronic pain — creates the stability from which the real work becomes possible.

The real work is a genuine therapeutic relationship: an ongoing conversation about what has been driving the eating, what it has been providing, and what has never felt possible to look at or to feel without the buffer it provides. That work takes the time it takes, and it cannot be replaced by a prescription.

Getting in Touch

The first conversation is free and completely confidential. There is no obligation of any kind.

Call directly: (646) 418-7077